Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

BACKGROUND/AIMS: Oral mesalazine is an important treatment for ulcerative colitis (UC), and non-adherence to mesalazine increases the risk of relapse. Controlled-release (CR) mesalazine has 2 formulations: tablets and granules. The relative acceptabilities of these formulations may influence patient...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intest Res
Päätekijät: Yagisawa, Keiji, Kobayashi, Taku, Ozaki, Ryo, Okabayashi, Shinji, Toyonaga, Takahiko, Miura, Miki, Hayashida, Mari, Saito, Eiko, Nakano, Masaru, Matsubara, Hajime, Hisamatsu, Tadakazu, Hibi, Toshifumi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Association for the Study of Intestinal Diseases 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361024/
https://ncbi.nlm.nih.gov/pubmed/30541227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2018.00078
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia